In March 2025, the company announced new strategies to get a direct-to-client supplying of its Wegovy weight loss drug. The company established a brand new pharmacy, known as NovoCare, which would charge shoppers $499 a month for access to the drug, less than 50 percent the expense of the drug by means of other pharmaceutical distribution networks.